Clinical Trials
35 trialsTesting of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center
SAA
University of California, Davis
CHIS
Assistance Publique - Hôpitaux de Paris
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
University of Chicago
Ovarian Tissue Cryopreservation for Fertility Preservation
University of Pittsburgh
AMBU-VAX
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
MIRAE
Sir Mortimer B. Davis - Jewish General Hospital
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Brain Inflammation Collaborative
Autoimmunity After Checkpoint Blockade
Abramson Cancer Center at Penn Medicine
Comparative Autoantibody and Immunologic Cell Marker Study
Emory University
IOG
UNC Lineberger Comprehensive Cancer Center
OTIS Humira Pregnancy Registry
University of California, San Diego
OTIS Cimzia Pregnancy Registry
University of California, San Diego
Apremilast Pregnancy Exposure Registry
University of California, San Diego
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
MiraKind
EXPLORE-MG2
Yale University
MELODY
Imperial College London
Biomarkers in Autoimmune Disease of Nervous System
Tongji Hospital
MINING
Washington University School of Medicine
CATCH CANCER
Assistance Publique - Hôpitaux de Paris
MBL RiskConseq
University of Haifa
Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases
The Second Affiliated Hospital of Chongqing Medical University
The Role of Autoimmunity and Obesity in Polycystic Ovary Syndrome
Sohag University
ADAPT-teleMG
Yale University
AREOLA-B
The Netherlands Cancer Institute
CIAD
Hellenic Cooperative Oncology Group
PROMISE-MG
Duke University
PROCID-DCH
University of Southern Denmark
CHIMeRA
Groupe Hospitalier Pitie-Salpetriere
Immune Checkpoint Inhibitors and Pre-existing Autoimmune Diseases
University Hospital, Brest
Study to Evaluate Immune Responses in Neurologically Normal Cancer Patients
Rockefeller University
Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases
Tianjin Medical University Cancer Institute and Hospital
OMS
National Pediatric Neuroinflammation Organization, Inc.
The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases
Jonsson Comprehensive Cancer Center
Characteristics of Patients With Thymoma in Chulalongkorn Hospital
Chulalongkorn University